A detailed history of Transcend Capital Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 5,342 shares of SNY stock, worth $257,965. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,342
Previous 5,536 3.5%
Holding current value
$257,965
Previous $268,000 14.93%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$48.54 - $58.53 $9,416 - $11,354
-194 Reduced 3.5%
5,342 $308,000
Q2 2024

Jul 02, 2024

BUY
$45.39 - $50.36 $5,446 - $6,043
120 Added 2.22%
5,536 $268,000
Q1 2024

May 03, 2024

SELL
$45.75 - $52.48 $14,365 - $16,478
-314 Reduced 5.48%
5,416 $263,000
Q4 2023

Feb 05, 2024

BUY
$43.13 - $54.79 $13,240 - $16,820
307 Added 5.66%
5,730 $284,000
Q3 2023

Oct 31, 2023

BUY
$50.95 - $55.2 $3,923 - $4,250
77 Added 1.44%
5,423 $290,000
Q2 2023

Jul 13, 2023

BUY
$50.45 - $57.18 $33,347 - $37,795
661 Added 14.11%
5,346 $288,000
Q1 2023

Apr 12, 2023

BUY
$45.86 - $54.45 $214,854 - $255,098
4,685 New
4,685 $254,000
Q3 2022

Oct 17, 2022

SELL
$37.22 - $100.5 $18,461 - $49,848
-496 Reduced 6.29%
7,389 $281,000
Q2 2022

Jul 12, 2022

BUY
$48.99 - $57.46 $35,272 - $41,371
720 Added 10.05%
7,885 $394,000
Q1 2022

Apr 20, 2022

BUY
$48.48 - $53.65 $34,711 - $38,413
716 Added 11.1%
7,165 $368,000
Q4 2021

Jan 20, 2022

BUY
$47.07 - $52.35 $6,731 - $7,486
143 Added 2.27%
6,449 $323,000
Q3 2021

Nov 04, 2021

BUY
$47.89 - $53.12 $301,994 - $334,974
6,306 New
6,306 $315,000
Q2 2021

Aug 13, 2021

SELL
$49.36 - $54.25 $270,591 - $297,398
-5,482 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$45.46 - $50.51 $8,682 - $9,647
191 Added 3.61%
5,482 $271,000
Q4 2020

Feb 12, 2021

BUY
$45.3 - $51.62 $239,682 - $273,121
5,291 New
5,291 $257,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.